Capsensixx AG (FRA:CPX) Beta: 0.1601 (As of Jul. 06, 2026)


FRA:CPX Capsensixx AG FRA:CPX
87 GF Score
Price €21.40
GF Value €27.46
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Capsensixx AG Beta?

Capsensixx AG FRA:CPX 87 Beta is 0.1601 as of Jul. 06, 2026. GuruFocus rates FRA:CPX with a GF Score™ of 87/100 and a GF Value™ of €27.46 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-06), Capsensixx AG's Beta is 0.1601.


Capsensixx AG  (FRA:CPX) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Capsensixx AG Beta Related Terms


Capsensixx AG Beta Historical Data

* Premium members only.

The historical data trend for Capsensixx AG's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Capsensixx AG Beta Chart

Capsensixx AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.31 0.26 -0.20 -0.13 -0.44

Capsensixx AG Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.20 -0.19 -0.13 0.19 -0.44

FRA:CPX vs BLK, BX, KKR: Beta Comparison

For the Asset Management subindustry, Capsensixx AG's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Capsensixx AG Beta vs Asset Management Industry

For the Asset Management industry and Financial Services sector, Capsensixx AG's Beta distribution charts can be found below:

* The bar in red indicates where Capsensixx AG's Beta falls into.


FRA:CPX
87GF Score
Capsensixx AG FRA:CPX
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Capsensixx AG Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.1601 mean?
Capsensixx AG (FRA:CPX) has a Beta of 0.1601 as of Jul. 06, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Capsensixx AG and its competitors.
Is Capsensixx AG's Beta too high?
Capsensixx AG's current Beta is 0.1601. Overall, Capsensixx AG has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Capsensixx AG's Beta compare to BLK and BX?
Capsensixx AG's Beta of 0.1601 can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for an Asset Management company?
A good Beta depends on the Asset Management industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Capsensixx AG and its competitors. Capsensixx AG's current Beta is 0.1601. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Capsensixx AG stock overvalued right now?
Based on GuruFocus' analysis, Capsensixx AG (FRA:CPX) is currently considered Modestly Undervalued. The stock's GF Value™ is €27.46, compared to a current price of €21.40 — trading 22.1% below its estimated fair value. The current Beta is 0.1601. Capsensixx AG's overall GF Score™ is 87/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Capsensixx AG (FRA:CPX), the current Beta is 0.1601 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Capsensixx AG (FRA:CPX) Overvalued in 2026?

Based on GuruFocus' analysis, Capsensixx AG stock appears to be undervalued. The current stock price of €21.40 is trading 22.1% below its estimated GF Value™ of €27.46. GuruFocus considers Capsensixx AG to be Modestly Undervalued.

Key valuation signals for FRA:CPX:

  • Beta: 0.1601
  • GF Value™: €27.46 vs. price of €21.40 (22.1% below fair value)
  • GF Score™: 87/100 with 5 warning signs

No single metric tells the full story. See the FRA:CPX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Capsensixx AG Business Description

Other Exchanges CPX:Germany
Address Bettinastrasse 57-59, Frankfurt, DEU, D-60325
Capsensixx AG is a provider of financial administration as a service. The company is divided into two segments namely Funds management, Administration and Accounting Segment which includes fund management and fund accounting; and Securitisations which provides Advisory services in the field of financial engineering, securitisation and provision of director and administrative services to corporate clients in Luxembourg.
87GF Score

Get the complete analysis for FRA:CPX

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€21.40
Price
€27.46
GF Value